• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常驻非小细胞肺癌微生物组的诊断和预后潜力。

Diagnostic and prognostic potential of the resident non-small cell lung cancer microbiome.

机构信息

N.N. Blokhin National Medical Research Center of Oncology Ministry of Health of the Russian Federation.

出版信息

Klin Lab Diagn. 2022 Aug 15;67(8):458-462. doi: 10.51620/0869-2084-2022-67-8-458-462.

DOI:10.51620/0869-2084-2022-67-8-458-462
PMID:36095082
Abstract

The data of a comprehensive comparative study of the taxonomic composition of the resident microbiome of tumors from 26 patients with non-small cell lung cancer are presented. Analysis of taxonomic diversity revealed 10 types, 280 genera and 788 species of microorganisms. The analysis of the relative content and prognostic significance was carried out for 62 dominant genera. Differences in the relative abundance of bacteria of the genera Acinetobacter, Halomonas, and Chryseobacterium between tumor and conditionally normal lung tissue were found, but their diagnostic potential was not confirmed. The correlation analysis did not reveal any relationship between the content of various genera of bacteria and the histological type of the tumor, its localization, and the age of the patients. Differences were found in the content of the studied bacteria depending on the stage of the disease, the presence of regional metastases and tumor differentiation. The prognostic significance of bacteria of the genera Variovorax and Pseudoclavibacter in non-small cell lung cancer was established. The results obtained can be used in the development of new effective methods for the diagnosis and prognosis of non-small cell lung cancer.

摘要

本文呈现了对 26 名非小细胞肺癌患者肿瘤常驻微生物组分类组成的综合比较研究的数据。对分类多样性的分析揭示了 10 种、280 属和 788 种微生物。对 62 种主要属的相对含量和预后意义进行了分析。在肿瘤和条件正常肺组织之间发现了不动杆菌属、盐单胞菌属和黄杆菌属细菌相对丰度的差异,但它们的诊断潜力尚未得到证实。相关性分析未发现各种细菌属的含量与肿瘤的组织学类型、定位和患者年龄之间存在任何关系。根据疾病分期、区域性转移和肿瘤分化,研究细菌的含量存在差异。还确定了非小细胞肺癌中拟杆菌属和假单胞菌属细菌的预后意义。所获得的结果可用于开发非小细胞肺癌的新的有效诊断和预后方法。

相似文献

1
Diagnostic and prognostic potential of the resident non-small cell lung cancer microbiome.常驻非小细胞肺癌微生物组的诊断和预后潜力。
Klin Lab Diagn. 2022 Aug 15;67(8):458-462. doi: 10.51620/0869-2084-2022-67-8-458-462.
2
The composition of lung microbiome in lung cancer: a systematic review and meta-analysis.肺癌中肺微生物组的组成:系统评价和荟萃分析。
BMC Microbiol. 2021 Nov 11;21(1):315. doi: 10.1186/s12866-021-02375-z.
3
Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.血清硫氧还蛋白和DJ-1在非小细胞肺癌患者中的诊断及预后价值
Tumour Biol. 2016 Feb;37(2):1949-58. doi: 10.1007/s13277-015-3994-x. Epub 2015 Sep 3.
4
Lung Microbiome Differentially Impacts Survival of Patients with Non-Small Cell Lung Cancer Depending on Tumor Stroma Phenotype.根据肿瘤基质表型,肺部微生物群对非小细胞肺癌患者的生存有不同影响。
Biomedicines. 2020 Sep 13;8(9):349. doi: 10.3390/biomedicines8090349.
5
Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non-small-cell lung cancer patients.共生微生物群有助于预测非小细胞肺癌患者对免疫检查点抑制剂的反应。
Cancer Sci. 2021 Aug;112(8):3005-3017. doi: 10.1111/cas.14979. Epub 2021 Jun 23.
6
The prognostic significance of intranodal isolated tumor cells and micrometastases in patients with non-small cell carcinoma of the lung.肺非小细胞癌患者淋巴结内孤立肿瘤细胞和微转移的预后意义。
J Thorac Cardiovasc Surg. 2003 Aug;126(2):551-7. doi: 10.1016/s0022-5223(03)00123-5.
7
Diagnostic and prognostic values of endothelial-cell-specific molecule-1 with malignant pleural effusions in patients with non-small cell lung cancer.内皮细胞特异性分子-1对非小细胞肺癌患者恶性胸腔积液的诊断及预后价值
Oncotarget. 2017 Jul 25;8(30):49217-49223. doi: 10.18632/oncotarget.17455.
8
Resident Microbiome of Kidney Tumors.肾肿瘤的常驻微生物群
Oncol Rev. 2024 May 21;18:1393664. doi: 10.3389/or.2024.1393664. eCollection 2024.
9
Taxonomic diversity of sputum microbiome in lung cancer patients and its relationship with chromosomal aberrations in blood lymphocytes.肺癌患者痰液微生物组的分类多样性及其与血淋巴细胞染色体畸变的关系。
Sci Rep. 2020 Jun 15;10(1):9681. doi: 10.1038/s41598-020-66654-x.
10
Serum reactive oxygen species modulator 1 (Romo1) as a potential diagnostic biomarker for non-small cell lung cancer.血清活性氧调节剂1(Romo1)作为非小细胞肺癌的潜在诊断生物标志物。
Lung Cancer. 2014 Aug;85(2):175-81. doi: 10.1016/j.lungcan.2014.05.023. Epub 2014 Jun 5.

引用本文的文献

1
Integrative multi-omics analysis of the microbiome and metabolome in bronchoalveolar lavage fluid from patients with early-stage lung cancer.早期肺癌患者支气管肺泡灌洗液体中微生物组和代谢组的综合多组学分析
Front Cell Infect Microbiol. 2025 Apr 28;15:1513270. doi: 10.3389/fcimb.2025.1513270. eCollection 2025.
2
Resident Microbiome of Kidney Tumors.肾肿瘤的常驻微生物群
Oncol Rev. 2024 May 21;18:1393664. doi: 10.3389/or.2024.1393664. eCollection 2024.
3
Saliva‑microbiome‑derived signatures: expected to become a potential biomarker for pulmonary nodules (MCEPN-1).
唾液微生物组衍生特征:有望成为肺结节(MCEPN-1)的潜在生物标志物。
BMC Microbiol. 2024 Apr 20;24(1):132. doi: 10.1186/s12866-024-03280-x.